Medical Journal, Health Articles

Health and medical news to help you live a better life

Archive for July, 2009

Applying cognitive neuropsychological principles to the rehabilitation of spanish readers with acquired dyslexia.

Authors: Cuetos F, Centeno JG
Cognitive neuropsychological models (CNMs) have been useful to generate a theory of aphasia rehabilitation. In contrast to the traditional syndrome approach, CNMs employ cognitive accounts to interpret language disturbances after brain damage. In this article, we apply CNMs to monolingual Spanish and bilingual Spanish-English readers with acquired dyslexia whose first language is Spanish. Although there are many studies of acquired dyslexia (reading errors associated with aphasia), they primarily have focused on English and French readers. Similar investigations on Spanish readers are limited. Unlike the opaque orthographic systems of English and French (inconsistent grapheme-to-phoneme relationships), Spanish has a mostly transparent orthography (regular …

Original post by Seminars in Speech and Language

Read entire article

No comments

Saxagliptin Approval: Finally, Competition for Merck’s Januvia

The FDA just approved saxagliptin, a diabetes medicine that will be co-marketed by Bristol-Myers Squibb and AstraZeneca. The drug, which will be sold under the brand name Onglyza, is in a relatively new class, called DPP-4 inhibitors, that can be taken along with older diabetes drugs.
Until now, Merck#8217;s Januvia has been the only drug in the class on the market in this country. But in late 2006, when Januvia was approved by the FDA, you wouldn#8217;t have guessed that Merck would have the market to itself for so long. That it has is a sign of the tough safety scrutiny the FDA has given to many new drugs in recent years.
The 2006 WSJ story on Januvia#8217;s approval noted that Galvus, a DPP-4 drug from Novartis, was also awaiting approval. But that drug was delayed, then delayed aga…

Original post by WSJ.com: Health Blog

Read entire article

No comments

My view on low carb diets? It’s complicated.

Q.#0160;#0160;#0160;#0160;From reading your blog it seems that a lot of your readers back low carb diets.#0160; Being a student studying nutrition, everything I have read has said that a low carb diet is terrible for your health.#0160; Can you address your views on this in your blog?
A.#0160;#0160;#0160;It#39;s something that comes up a lot on the blog and always seems to elicit very strong opinions.#0160; Several regular commenters are quite ardent about the evils of carbohydrates.#0160;#0160;My views are somewhat more moderate.#0160; I do think that refined carbohydrates are a big part of the problem with the Western diet.#0160; I think that overconsumption of refined carbohydrates (especially in the context of a sedentary lifestyle) contributes to obesity, diabetes and re…

Original post by The ND Blog: Notes from the Nutritionista by Monica Reinagel, L.D.N., C.N.S.

Read entire article

No comments

Type 2 Diabetes Raises the Risk of Parkinsons Disease

A shocking discovery is just coming out linking Type 2 Diabetes to Parkinson#8217;s Disease. There are nearly 1.5 million Americans diagnosed with Parkinson#8217;s Disease, according to the National Parkinsons Foundation, which is a disease affecting brain cells and neurons causing reduced levels of dopamine. The lowered levels of dopamine cause such side effects as tremors, paralysis and death.

#8220;Scottie#8221; also suffered from Type 2 diabetes and Parkinson#8217;s disease during Star Trek

Overall, after adjusting for other possible risk factors for Parkinson#8217;s disease, men and women with type 2 diabetes were 83 percent more likely to develop Parkinson#8217;s disease than those without it.
Although common lifestyle factors may play a role, researchers say more study is …

Original post by Battle Diabetes Blog

Read entire article

No comments

What a New Era of Pharma Marketing Means to (Diabetes) Patients

As you may have noticed, I#8217;m fascinated with where new Web-enabled communication tools are taking us in the world of medicine in healthcare. I#8217;m also a huge admirer of the work of the outspoken and sage John Mack, publisher of Pharma Marketing News and author of the Pharma Marketing Blog.  I was therefore delighted when [...] (Source: Diabetes Mine)

Original post by Diabetes Mine

Read entire article

No comments

How Children View And Treat Their Peers With Undesirable Characteristics: K-State Study

A study by Kansas State University researchers is looking at how children perceive and interact with peers who have various undesirable characteristics, such as being overweight or aggressive. The researchers’ study explored children’s perceptions of the ability of the peer to control or change such traits.

Original post by Diabetes Mine

Read entire article

No comments

New Urine Test Detects Chlamydia In Men

A new rapid urine test for chlamydia in men identified 84% of infections, according to a study of 1,200 men published Tuesday in the British Medical Journal, Reuters reports.

Original post by Diabetes Mine

Read entire article

No comments

WFP To Cut $3B From Programs Because Of Budget Shortfall, Executive Director Says

Low donation levels are causing the World Food Programme (WFP) to fall short of feeding the most critically hungry people in the world, and the agency “has so far received only $1.8 billion and has had to cut back rations and programs to the 108 million people it serves, said Josette Sheeran,” WFP’s executive director,

Original post by Diabetes Mine

Read entire article

No comments

Recession-Battered States Cut Funding For Health Services

Under economic pressure, states are slashing funding for health services from Connecticut to California. The cuts frustrate providers and lawmakers are looking for ways to limit harm. The

Original post by Diabetes Mine

Read entire article

No comments

Lobbyists Continue Pressing Their Cases

Pharmaceutical companies, hospitals, advocacy groups and others with a stake in health reform continue to lobby in hopes of winning concessions in the overhaul, or at least surviving the changes unscathed. “One of the groups key to working any deal is the pharmaceutical industry, which has been quite active behind the scenes,” National Public Radio reports.

Original post by Diabetes Mine

Read entire article

No comments

Next Page »